InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ACTUATE THERAPEUTICS, INC.

ACTU Clue Score35
United States Fiscal year ends December CIK 0001652935
Add to watchlist

What the insiders did Net buying

Individual transactions

21
Insider
Date
Role
Action
Shares
Price
Amount
Daniel M Schmitt
28 Oct 2026
President, CEO and Director
Buy
140,844
$0.36
$50.00K
Todd S Thomson
5 Jan 2026
Director
Sell indirect
280,000
$5.80
$1.62M
Aaron G.L. Fletcher
27 Jun 2025
Director
Buy indirect
71,428
$7.00
$500.00K
Leslie W. Kreis
27 Jun 2025
Director
Buy indirect
71,428
$7.00
$500.00K
Bios Equity COF, LP
27 Jun 2025
Director
Buy indirect
71,428
$7.00
$500.00K
Leslie W. Kreis
14 Aug 2024
10% owner
Sold after exercise indirect
2,324
$9.00
$20.92K
Leslie W. Kreis
14 Aug 2024
10% owner
Sold after exercise indirect
17,361
$9.00
$156.25K
Leslie W. Kreis
14 Aug 2024
10% owner
Sold after exercise indirect
5,314
$9.00
$47.83K
Leslie W. Kreis
14 Aug 2024
10% owner
Buy indirect
125,000
$8.00
$1.00M
Leslie W. Kreis
14 Aug 2024
10% owner
Buy indirect
375,000
$8.00
$3.00M
Aaron G.L. Fletcher
14 Aug 2024
Director
Sold after exercise indirect
2,324
$9.00
$20.92K
Aaron G.L. Fletcher
14 Aug 2024
Director
Sold after exercise indirect
17,361
$9.00
$156.25K
Aaron G.L. Fletcher
14 Aug 2024
Director
Sold after exercise indirect
5,314
$9.00
$47.83K
Aaron G.L. Fletcher
14 Aug 2024
Director
Buy indirect
125,000
$8.00
$1.00M
Aaron G.L. Fletcher
14 Aug 2024
Director
Buy indirect
375,000
$8.00
$3.00M
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
2,324
$9.00
$20.92K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
17,361
$9.00
$156.25K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
5,314
$9.00
$47.83K
Bios Equity COF, LP
14 Aug 2024
Director
Buy indirect
125,000
$8.00
$1.00M
Bios Equity COF, LP
14 Aug 2024
Director
Buy indirect
375,000
$8.00
$3.00M
Todd S Thomson
14 Aug 2024
Director
Sold after exercise indirect
18,750
$8.00
$150.00K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 10
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 31,648,232
History held since 14 Aug 2024